2023

  1. ICD-10-CM Codes
    2. ›
  2. C00-D49
    3. ›
  3. D00-D09
    4. ›
  4. D09-
    5. ›
  5. 2023 ICD-10-CM Diagnosis Code D09.0

2023 ICD-10-CM Diagnosis Code D09.0

Carcinoma in situ of bladder

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
  • D09.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2023 edition of ICD-10-CM D09.0 became effective on October 1, 2022.
  • This is the American ICD-10-CM version of D09.0 - other international versions of ICD-10 D09.0 may differ.
The following code(s) above D09.0 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to D09.0:
  • C00-D49
    2023 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • D00-D09
    2023 ICD-10-CM Range D00-D09

    In situ neoplasms

    Includes
    • Bowen's disease
    • erythroplasia
    • grade III intraepithelial neoplasia
    • Queyrat's erythroplasia
    In situ neoplasms
  • D09
    ICD-10-CM Diagnosis Code D09

    Carcinoma in situ of other and unspecified sites

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Type 1 Excludes
    Carcinoma in situ of other and unspecified sites
Approximate Synonyms
  • Cancer in situ of urinary bladder
Clinical Information
  • Also known as carcinoma in situ of the urinary bladder or high grade intraurothelial neoplasia, this is a flat lesion of the transitional cell epithelium characterized by severe cytologic atypia. This lesion is confined to the urothelium, and is a precursor of invasive transitional cell carcinoma of the bladder.
  • Stage 0is includes: tis, n0, m0. Tis: carcinoma in situ: "flat tumor". N0: no regional lymph node metastasis. M0: no distant metastasis. (ajcc 6th and 7th eds.)
ICD-10-CM D09.0 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
  • 656 Kidney and ureter procedures for neoplasm with mcc
  • 657 Kidney and ureter procedures for neoplasm with cc
  • 658 Kidney and ureter procedures for neoplasm without cc/mcc
  • 686 Kidney and urinary tract neoplasms with mcc
  • 687 Kidney and urinary tract neoplasms with cc
  • 688 Kidney and urinary tract neoplasms without cc/mcc

Convert D09.0 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
ICD-10-CM Codes Adjacent To D09.0
D07.3 Carcinoma in situ of other and unspecified female genital organs
D07.30 Carcinoma in situ of unspecified female genital organs
D07.39 Carcinoma in situ of other female genital organs
D07.4 Carcinoma in situ of penis
D07.5 Carcinoma in situ of prostate
D07.6 Carcinoma in situ of other and unspecified male genital organs
D07.60 Carcinoma in situ of unspecified male genital organs
D07.61 Carcinoma in situ of scrotum
D07.69 Carcinoma in situ of other male genital organs
D09 Carcinoma in situ of other and unspecified sites
D09.0 Carcinoma in situ of bladder
D09.1 Carcinoma in situ of other and unspecified urinary organs
D09.10 Carcinoma in situ of unspecified urinary organ
D09.19 Carcinoma in situ of other urinary organs
D09.2 Carcinoma in situ of eye
D09.20 Carcinoma in situ of unspecified eye
D09.21 Carcinoma in situ of right eye
D09.22 Carcinoma in situ of left eye
D09.3 Carcinoma in situ of thyroid and other endocrine glands
D09.8 Carcinoma in situ of other specified sites
D09.9 Carcinoma in situ, unspecified

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Advertise with Us | License ICD10 Data

Copyright © | ICD10data.com